Take-home message on CAR T-cell therapy for lymphoma from ASH 2017
The TAP CLARITY study: latest results and future plans
The real cost of hematological cancer care explained
How are immunotherapies re-shaping the treatment of lymphoma
Catherine Bollard et al.
HSV-TK cells as adjunctive treatment for haplo-HSCT